Alexandre Rolim da Paz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alexandre Rolim da Paz has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Camila Gonçalves Pinheiro
Dermatology Service, Nova Esperança Faculty of Medicine, João Pessoa, PB, Brazil
2 shared publications - Lafayette Cavalcanti Bezerra Dias Cruz
Dermatology Service, Faculdade de Medicina Nova Esperança, João Pessoa, PB, Brazil; Oncology Service, Hospital Napoleão Laureano, João Pessoa, PB, Brazil
2 shared publications - Luciana Cavalcante Trindade
Doutoramento em Ciências da Saúde - Centro Universitário FMABC – Santo André, São Paulo, Brazil
2 shared publications - Ana Clara Tosta Telles
Universidade Federal da Bahia (UFBA), Instituto de Ciências da Saúde (ICS). Programa de Pós-Graduação em Processos Interativos dos Órgãos e Sistemas (PPGPIOS). Salvador (BA), Brasil
1 shared publication - Bruna Katarina Gomes Felipe Gouveia
Universidade Tabosa de Almeida
1 shared publication - Bruno da Silva Lisboa
State University of Feira de Santana, Department of Health
1 shared publication
Latest Publications
- Open Access
- 2 May 2024
- Published by Georg Thieme Verlag KG in Brazilian Journal of Oncology
- Vol. 20 (CP) , 1-10
Immunohistochemistry and next-generation sequencing for NTRK fusion detection in differentiated thyroid cancer of children, adolescents and young adults
Introduction: Pan-TRK immunohistochemistry staining can assess the protein expression from NTRK gene fusions. A little is known about its utility in differentiated thyroid cancer samples from children, adolescents, and young adults patients. Objective:Investigate pan-TRKimmunohistochemistry sensitivity and specificity in differentiated thyroid cancer samples from children, adolescents, and young adults patients. Methods: Tumor samples obtained from 79 children, adolescents, and young adults patients (age <21 years) diagnosed with differentiated thyroid cancer between January, 2010 and January, 2021 were retrospectively recruited from four health centers from state of Bahia e Paraíba, Brazil. NTRK gene fusion testing of all archival FFPE tumor samples: pan-TRK immunohistochemistry staining for TRKA, TRKB and TRKC protein expression were performed and then analyzed with RNA-based nextgeneration sequencing assay to confirm immunohistochemistry pan-TRK result and elucidate fusion partner. Results: Pan-TRK immunohistochemistry: 3 of 79 cases had positive pan-TRK expression: next-generation sequencing; 4 were identified with NTRK gene fusion, pan-TRK immunohistochemistry was negative in all 4 NTRK next-generation sequencing-positive cases. 25 of 79 NTRK next-generation sequencing-negative control cases had concordant negative pan-TRK immunohistochemistry results. Therefore, our rate of false positive pan-TRK immunohistochemistry results was 3/25 (12%). The overall results for pan-TRK immunohistochemistry in our cohort of next-generation sequencing-negative cases was: (i) sensitivity (0%), (ii) specificity (96%), (iii) positive predictive value (94.7%), (iv) negative predictive value (91%). Conclusion: Pan-TRK immunohistochemistry was not a tissue-efficient screen for NTRK fusions in differentiated thyroid cancer from children, adolescents, and young adults patients. This is the largest cohort of from children, adolescents, and young adults differentiated thyroid cancer cases stained with pan-TRK immunohistochemistry, and it is the first to detail the sensitivity and specificity of pan-TRK immunohistochemistry regarding the data obtained by targeted RNA-based next-generation sequencing panel in differentiated thyroid cancer.
- 2 May 2024
- Published by Georg Thieme Verlag KG in Brazilian Journal of Oncology
- Vol. 20 (CP) , 1-10
Open AccessImmunohistochemistry and next-generation sequencing for NTRK fusion detection in differentiated thyroid cancer of children, adolescents and young adults
Introduction: Pan-TRK immunohistochemistry staining can assess the protein expression from NTRK gene fusions. A little is known about its utility in differentiated thyroid cancer samples from children, adolescents, and young adults patients. Objective:Investigate pan-TRKimmunohistochemistry sensitivity and specificity in differentiated thyroid cancer samples from children, adolescents, and young adults patients. Methods: Tumor samples obtained from 79 children, adolescents, and young adults patients (age <21 years) diagnosed with differentiated thyroid cancer between January, 2010 and January, 2021 were retrospectively recruited from four health centers from state of Bahia e Paraíba, Brazil. NTRK gene fusion testing of all archival FFPE tumor samples: pan-TRK immunohistochemistry staining for TRKA, TRKB and TRKC protein expression were performed and then analyzed with RNA-based nextgeneration sequencing assay to confirm immunohistochemistry pan-TRK result and elucidate fusion partner. Results: Pan-TRK immunohistochemistry: 3 of 79 cases had positive pan-TRK expression: next-generation sequencing; 4 were identified with NTRK gene fusion, pan-TRK immunohistochemistry was negative in all 4 NTRK next-generation sequencing-positive cases. 25 of 79 NTRK next-generation sequencing-negative control cases had concordant negative pan-TRK immunohistochemistry results. Therefore, our rate of false positive pan-TRK immunohistochemistry results was 3/25 (12%). The overall results for pan-TRK immunohistochemistry in our cohort of next-generation sequencing-negative cases was: (i) sensitivity (0%), (ii) specificity (96%), (iii) positive predictive value (94.7%), (iv) negative predictive value (91%). Conclusion: Pan-TRK immunohistochemistry was not a tissue-efficient screen for NTRK fusions in differentiated thyroid cancer from children, adolescents, and young adults patients. This is the largest cohort of from children, adolescents, and young adults differentiated thyroid cancer cases stained with pan-TRK immunohistochemistry, and it is the first to detail the sensitivity and specificity of pan-TRK immunohistochemistry regarding the data obtained by targeted RNA-based next-generation sequencing panel in differentiated thyroid cancer.
- 3 May 2022
- Published by SAGE Publications in International Journal of Surgical Pathology
- Vol. 31 (1) , 38-45
Clear Cell Papillary Renal Cell Tumors: A Study of 42 Tumors with Emphasis on the Fibrous Capsule, Cystic Component, and GATA3 Immunohistochemistry
Clear cell papillary renal cell tumor is a common and sometimes underdiagnosed renal cell neoplasm. Its proper recognition is important because its diagnosis implies a remarkably high probability of indolent behavior. This study aimed to evaluate the frequency of a fibrous capsule, a cystic component, and a GATA3 expression in clear cell papillary renal cell tumors. We assessed 419 renal cell neoplasms from three institutions located in northeastern Brazil and identified 42 clear cell papillary renal cell tumors (from 39 patients), which were the fourth most common renal cell neoplasm. These tumors commonly exhibited fibrous capsules (all showed complete or partial capsules) and cystic component (93%). Eighteen out of 42 tumors (43%) showed some expression of GATA3, and weak and focal staining was common among the positive tumors. Clear cell papillary renal cell tumor must always be included in the differential diagnosis of predominantly cystic renal cell neoplasms. As GATA3 is inconsistently expressed in clear cell papillary renal cell tumors, it is not useful in this diagnosis.
- 3 May 2022
- Published by SAGE Publications in International Journal of Surgical Pathology
- Vol. 31 (1) , 38-45
Clear Cell Papillary Renal Cell Tumors: A Study of 42 Tumors with Emphasis on the Fibrous Capsule, Cystic Component, and GATA3 Immunohistochemistry
Clear cell papillary renal cell tumor is a common and sometimes underdiagnosed renal cell neoplasm. Its proper recognition is important because its diagnosis implies a remarkably high probability of indolent behavior. This study aimed to evaluate the frequency of a fibrous capsule, a cystic component, and a GATA3 expression in clear cell papillary renal cell tumors. We assessed 419 renal cell neoplasms from three institutions located in northeastern Brazil and identified 42 clear cell papillary renal cell tumors (from 39 patients), which were the fourth most common renal cell neoplasm. These tumors commonly exhibited fibrous capsules (all showed complete or partial capsules) and cystic component (93%). Eighteen out of 42 tumors (43%) showed some expression of GATA3, and weak and focal staining was common among the positive tumors. Clear cell papillary renal cell tumor must always be included in the differential diagnosis of predominantly cystic renal cell neoplasms. As GATA3 is inconsistently expressed in clear cell papillary renal cell tumors, it is not useful in this diagnosis.
- Open Access
- 1 March 2022
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 97 (2) , 179-183
Linfoma cutâneo primário de células B tipo perna: boa resposta com o protocolo RADHAP 21
- 1 March 2022
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 97 (2) , 179-183
Open AccessLinfoma cutâneo primário de células B tipo perna: boa resposta com o protocolo RADHAP 21
- Open Access
- 15 January 2022
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 97 (2) , 179-183
Primary cutaneous B-cell lymphoma leg type: good response with the RADHAP 21 protocol
- 15 January 2022
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 97 (2) , 179-183
Open AccessPrimary cutaneous B-cell lymphoma leg type: good response with the RADHAP 21 protocol
- Open Access
- 23 April 2020
- Published by Research, Society and Development in Research, Society and Development
- Vol. 9 (7) , e852974960
Osteomielite associada à Actinomyces sp. em osso mandibular: relato de caso
A actinomicose é uma infecção rara, causada por microorganismos do gênero Actinomyces. Sua apresentação clínica pode se assemelhar ou mascarar outros processos infecciosos, o que torna complexo seu diagnóstico e compromete o êxito terapêutico. O objetivo deste trabalho é relatar um caso de osteomielite decorrente de uma infecção bacteriana, discutir as manifestações clínicas, formas de diagnóstico e tratamento. Trata-se de um estudo descritivo, retrospectivo, qualitativo feito por meio da técnica de observação direta. Paciente do sexo masculino, leucoderma, 65 anos de idade, compareceu ao serviço de cirurgia bucomaxilofacial com queixa álgica em região anterior de mandíbula e histórico de exodontia há 5 meses na região com episódios de drenagem de secreção purulenta. Ao exame físico observou-se ausência do dente 31 e tecidos íntegros, sendo solicitado exame radiográfico, onde observou-se sequestro ósseo em região de osso alveolar, com hipótese diagnóstica de osteomielite. O tratamento preconizado foi procedimento cirúrgico com exérese da área radiopaca, associado ao uso de um agente antimicrobiano. Avaliação histopatológica confirmou o processo infeccioso associado a colônias de bactérias Actinomyces sp.; o paciente evoluiu bem com completa remissão do processo infeccioso. Desta forma, a confirmação histopatológica é uma importante ferramenta para o rápido diagnóstico e estabelecimento de tratamento efetivo, tendo em vista que a actinomicose faz diagnóstico diferencial com diversas doenças e tem alto poder destrutivo local.
- 23 April 2020
- Published by Research, Society and Development in Research, Society and Development
- Vol. 9 (7) , e852974960
Open AccessOsteomielite associada à Actinomyces sp. em osso mandibular: relato de caso
A actinomicose é uma infecção rara, causada por microorganismos do gênero Actinomyces. Sua apresentação clínica pode se assemelhar ou mascarar outros processos infecciosos, o que torna complexo seu diagnóstico e compromete o êxito terapêutico. O objetivo deste trabalho é relatar um caso de osteomielite decorrente de uma infecção bacteriana, discutir as manifestações clínicas, formas de diagnóstico e tratamento. Trata-se de um estudo descritivo, retrospectivo, qualitativo feito por meio da técnica de observação direta. Paciente do sexo masculino, leucoderma, 65 anos de idade, compareceu ao serviço de cirurgia bucomaxilofacial com queixa álgica em região anterior de mandíbula e histórico de exodontia há 5 meses na região com episódios de drenagem de secreção purulenta. Ao exame físico observou-se ausência do dente 31 e tecidos íntegros, sendo solicitado exame radiográfico, onde observou-se sequestro ósseo em região de osso alveolar, com hipótese diagnóstica de osteomielite. O tratamento preconizado foi procedimento cirúrgico com exérese da área radiopaca, associado ao uso de um agente antimicrobiano. Avaliação histopatológica confirmou o processo infeccioso associado a colônias de bactérias Actinomyces sp.; o paciente evoluiu bem com completa remissão do processo infeccioso. Desta forma, a confirmação histopatológica é uma importante ferramenta para o rápido diagnóstico e estabelecimento de tratamento efetivo, tendo em vista que a actinomicose faz diagnóstico diferencial com diversas doenças e tem alto poder destrutivo local.